Differences in target mRNAs from FAK-WT and FAK-KD embryos during development
| Protein name | Fold reduction (WT/KD) |
| Tropomodulin-1 | 13.1 |
| VCAM-1 | 7.4 |
| Caveolin-1 | 6.4 |
| Robo-4 | 4.9 |
| Rgs5 | 4.7 |
| CD31 | 3.6 |
| WAS | 4.3 |
| ESAM-1 | 2.7 |
| ICAM-2 | 2.6 |
| α-SMA | 2.3 |
| SEMA6B | 2.1 |
| Protein name | Fold reduction (WT/KD) |
| Tropomodulin-1 | 13.1 |
| VCAM-1 | 7.4 |
| Caveolin-1 | 6.4 |
| Robo-4 | 4.9 |
| Rgs5 | 4.7 |
| CD31 | 3.6 |
| WAS | 4.3 |
| ESAM-1 | 2.7 |
| ICAM-2 | 2.6 |
| α-SMA | 2.3 |
| SEMA6B | 2.1 |
Illumina MouseWG-6 v2.0 Expression BeadChip analyses (45,200 targets) were performed. Selected mRNAs with greater than twofold change are shown. WAS, Wiskott–Aldrich syndrome; ESAM-1, endothelial selective adhesion molecule–1; ICAM-2, intercellular adhesion molecule–2; α-SMA, α–smooth muscle actin.